Retraction Note: Interactions Between Th1 Cells and Tregs Affect Regulation of Hepatic Fibrosis in Biliary Atresia Through the IFN-γ/STAT1 Pathway

Jie Wen,Ying Zhou,Jun Wang,Jie Chen,Wenbo Yan,Jin Wu,Junkai Yan,Kejun Zhou,Yongtao Xiao,Yang Wang,Qiang Xia,Wei Cai

DOI: https://doi.org/10.1038/s41418-019-0428-0

2019-01-01

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

What problem does this paper attempt to address?

RETRACTED ARTICLE:Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway

Jie Wen,Ying Zhou,Jun Wang,Jie Chen,Wenbo Yan,Jin Wu,Junkai Yan,Kejun Zhou,Yongtao Xiao,Yang Wang,Qiang Xia,Wei Cai

DOI: https://doi.org/10.1038/cdd.2017.31

2017-01-01

Abstract:Regulatory T cells (Tregs) and CD4+ T helper (Th) cells have important roles in bile duct injury of biliary atresia (BA). However, their impacts on liver fibrosis are undefined. Between 2013 and 2016, 146 patients with various stages of BA were enrolled in this study. Peripheral blood, liver biopsy and lymph node samples were collected. Flow cytometry, magnetic cell sorting and immunostaining were used to characterize lymphocytes from BA patients. Deficiency of Tregs was observed along with increased Th1, Th2 and Th17 frequencies in the peripheral blood and livers of BA patients. The levels of peripheral and intrahepatic Th1 cells positively correlated with the stage of liver fibrosis. Furthermore, Th1 cells were located in close proximity to activated hepatic stellate cells (HSCs) and areas of fibrosis in BA livers. In culture, Th1 cells accelerated the proliferation and secretion of profibrogenic markers of HSCs through the IFN-γ/STAT1 pathway. Of note, Tregs blocked the Th1-stimulated effects on HSCs by inhibiting Th1-induced activation of STAT1. Consistent with the results of in vitro study, intrahepatic IFN-γ/STAT1 levels increased in relation to the severity of liver fibrosis in BA patients, and the altered balance between MMP2 and TIMP1 expressions in livers may contribute to increased deposition of extracellular matrix and fibrosis. Finally, to identify the effects of Th1 cells on Tregs, we demonstrated that Th1 cells upregulated the proportion of aTreg cells by secreting IFN-γ cytokine. Thus, aberrant Th1 immune responses in BA promote the proliferation and secretion of HSCs through the IFN-γ/STAT1 pathway. The regulation of HSCs by the interactions between Tregs and Th1 cells might be part of the mechanism underlying progressive liver fibrosis and may be a suitable target for therapy.
[Corrigendum] TLR4 mediates inflammation and hepatic fibrosis induced by chronic intermittent hypoxia in rats

Zhi-Peng Lin,Hui-Li Lin,Xue-Ping Yu,Yi-Juan Zheng,Si-Yu Cheng

DOI: https://doi.org/10.3892/mmr.2021.12144

IF: 3.423

2021-05-10

Molecular Medicine Reports

Abstract:Following the publication of the above article, the authors have realized that the first grant number featured in the Funding section of the Declarations on p. 658 appeared incorrectly: The text here should have been written as 'grant nos. 2018J01199, 2018Y0032 and 2016J01441' instead of 'grant nos. 2018J0105, 2018Y0032 and 2016J01441'. The authors regret their oversight in providing this incorrect information in the Funding section of their paper. They thank the Editor of <em>Molecular Medicine Reports</em> for allowing them the opportunity to publish this corrigendum, and apologize to the readership of the Journal and to the funding body in question for any inconvenience caused. [the original article was published in <em>Molecular Medicine Reports</em> 22: 651‑660, 2020; DOI: 10.3892/mmr.2020.11134]

oncology,medicine, research & experimental
Corrigendum to ‘therapeutic HNF4A Mrna Attenuates Liver Fibrosis in a Preclinical Model’ [J Hepatol (2021) 1420-1433]

Taihua Yang,Marion Poenisch,Rajendra Khanal,Qingluan Hu,Zhen Dai,Ruomeng Li,Guangqi Song,Qinggong Yuan,Qunyan Yao,Xizhong Shen,Richard Taubert,Bastian Engel,Elmar Jaeckel,Arndt Vogel,Christine S Falk,Axel Schambach,Daniela Gerovska,Marcos J Araúzo-Bravo,Florian W R Vondran,Tobias Cantz,Nigel Horscroft,Asha Balakrishnan,Frédéric Chevessier,Michael Ott,Amar Deep Sharma

DOI: https://doi.org/10.1016/j.jhep.2022.03.023

IF: 25.7

2022-01-01

Journal of Hepatology

Abstract:It has come to our attention that in the financial support statement, we erroneously acknowledged funding support from the PLUS3 programme of Boehringer Ingelheim. Funding support was actually received from the PLUS3 programme of the Boehringer Ingelheim foundation (an independent non-profit foundation). We apologise for any inconvenience caused.
Regulatory T Cells with a Defect in Inhibition on Co-Stimulation Deteriorated Primary Biliary Cholangitis

Jianing Chen,Xianliang Hou,Hongyu Jia,Guangying Cui,Zhongwen Wu,Lin Wang,Chong Lu,Wei Wu,Yingfeng Wei,Toshimitsu Uede,Lanjuan Li,Zhexiong Lian,Hongyan Diao

DOI: https://doi.org/10.18632/oncotarget.22658

2017-01-01

Oncotarget

Abstract:Regulatory T cells (Tregs) play an indispensable role in the progression of primary biliary cholangitis (PBC). Although Tregs could normalize costimulation in in vivo and in vitro models, it is obscure whether and how Tregs mediate these effects in PBC. Herein we focused on the quantitative and functional characteristics of Tregs in PBC. The number and proportion of Tregs, and the production of interleukin (IL)-10 were all significantly less in the PBC patients than in the healthy controls (HCs). In addition, compared to the HCs, the costimulatory CD86 of the circulation and liver were significantly higher in the patients with PBC. CD86 expression on CD1c+ cells negatively correlated with the proportion of Tregs. There was also a positive correlation between mayo risk score and the ratio of CD86/Treg. In vitro experiments showed that inhibition of CD86 expression on CD1c+ cells by Tregs was significantly weakened in the PBC patients. Furthermore, the autoantibodies from the PBC patients could promote CD86 expression on CD1c+ cells and transforming growth factor-β production by human hepatic stellate cells. Overall, Tregs declined in inhibition on co-stimulation expression in the presence of autoantibodies, which could be associated to PBC-related bile duct injury and fibrosis. This indicated that maintenance of balance of co-stimulation and Tregs could be beneficial for PBC.
Regulatory T cells (Tregs) in liver fibrosis

Ke-jia Wu,Qu-fei Qian,Jin-ren Zhou,Dong-lin Sun,Yun-fei Duan,Xi Zhu,Kurt Sartorius,Yun-jie Lu

DOI: https://doi.org/10.1038/s41420-023-01347-8

2023-02-10

Cell Death Discovery

Abstract:The ability of the human liver to both synthesize extracellular matrix(ECM), as well as regulate fibrogenesis, are integral functions to maintaining homoeostasis. Chronic liver injury stimulates fibrogenesis in response to the imbalance between ECM accumulation and fibrosis resolution. Liver disease that induces fibrogenesis is associated with multiple risk factors like hepatitis infection, schistosomiasis, alcohol, certain drugs, toxicants and emerging aetiology like diabetes and obesity. The activation of hepatic stellate cells (HSCs), whose function is to generate and accumulate ECM, is a pivotal event in liver fibrosis. Simultaneously, HSCs selectively promote regulatory T-cells (Tregs) in an interleukin-2–dependent pattern that displays a dual relationship. On the one hand, Tregs can protect HSCs from NK cell attack, while on the other hand, they demonstrate an inhibitory effect on HSCs. This paper reviews the dual role of Tregs in liver fibrogenesis which includes its promotion of immunosuppression, as well as its activation of fibrosis. In particular, the balance between Tregs and the Th17 cell population, which produce interleukin (IL)-17 and IL-22, is explored to demonstrate their key role in maintaining homoeostasis and immunoregulation. The contradictory roles of Tregs in liver fibrosis in different immune microenvironments and molecular pathways need to be better understood if they are to be deployed to manage this disease.

cell biology
Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice.

Xiaohui Zhang,Jinli Lou,Li Bai,Yu Chen,Sujun Zheng,Zhongping Duan

DOI: https://doi.org/10.12659/msm.899725

2017-01-01

Medical Science Monitor

Abstract:Background: Liver fibrosis is the result of chronic inflammation and repair, and many immune cells contribute to the process. Regulatory T cells (Tregs) mediate immune tolerance and are highly expressed in liver fibrosis. However, few reports have studied the specific effects of Tregs on regulating immune cells in liver fibrosis. The present study aimed to investigate the regulation of Tregs on intrahepatic immune cells in liver fibrosis by depleting Tregs in mice.Material/Methods: Liver fibrosis was induced by carbon tetrachloride, and an anti-CD25 mAb (PC61) was used to deplete Tregs. Liver fibrosis and injury were reflected by immuno.uorescence staining and alanine aminotransferase level. The expressions of immune cell Tregs and cytokines were detected by flow cytometry and/or real-time PCR. Interferon-gamma (IFN-gamma) concentration was measured by ELISA.Results: Tregs were rich in fibrotic livers; after Tregs depletion, the intrahepatic CD4(+) T cell and Kupffer cells (KC) populations did not change compared with liver fibrosis, but CD8(+) T cells were slightly elevated. However, natural killer (NK) cells and IFN-gamma levels were significantly decreased in fibrosis and increased after Tregs depletion. Interesting, we found Tregs promoted KC M1/M2 balance to M2, because inducible nitric oxide synthase (M1) was increased but arginase-1 (M2) was reduced after depleting Tregs. Furthermore, in isolated KCs from livers, IL-12 (M1) was increased, but TGF-beta (M2) was reduced after depleting Tregs, compared with fibrotic livers.Conclusions: Tregs are involved in the immune regulation of liver fibrosis, primarily by suppressing NK cells and M1 KCs, and mildly suppressing CD8(+) T cells.
Publisher Correction: the Transcriptional Coactivator TAZ Regulates Reciprocal Differentiation of TH17 Cells and Treg Cells.

Jing Geng,Shujuan Yu,Hao Zhao,Xiufeng Sun,Xun Li,Ping Wang,Xiaolin Xiong,Lixin Hong,Changchuan Xie,Jiahui Gao,Yiran Shi,Jiaqi Peng,Randy L Johnson,Nengming Xiao,Linrong Lu,Jiahuai Han,Dawang Zhou,Lanfen Chen

DOI: https://doi.org/10.1038/s41590-018-0055-9

IF: 30.5

2017-01-01

Nature Immunology

Abstract:In the version of this article initially published, the institution name for affiliation 3 (Maryland Anderson Cancer Center) was incorrect. The correct institution is MD Anderson Cancer Center. The error has been corrected in the HTML and PDF versions of the article.
Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Corrigendum: TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure

Chunli Xu,Yinping Lu,Xin Zheng,Xuemei Feng,Xuecheng Yang,Joerg Timm,Jun Wu,Baoju Wang,Mengji Lu,Dongliang Yang,Jia Liu

DOI: https://doi.org/10.3389/fimmu.2020.01566

IF: 7.3

2020-07-24

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2017.01609.].

immunology
Correction To: A Novel Role of Glutathione S-transferase A3 in Inhibiting Hepatic Stellate Cell Activation and Rat Hepatic Fibrosis.

Haihua Chen,Qixin Gan,Congying Yang,Xiongqun Peng,Jiao Qin,Sisi Qiu,Yanzhi Jiang,Sha Tu,Ying He,Shenglan Li,Huixiang Yang,Lijian Tao,Yu Peng

DOI: https://doi.org/10.1186/s12967-020-02346-4

IF: 8.44

2020-01-01

Journal of Translational Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.
Correction to: TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells

Zhijian Cai,Wei Zhang,Min Li,Yinpu Yue,Fei Yang,Lei Yu,Xuetao Cao,Jianli Wang

DOI: https://doi.org/10.1038/s41423-019-0338-6

2019-01-01

Abstract:n amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Jiajie Hou,He Zhang,Jun Liu,Zhenjun Zhao,Jianye Wang,Zhike Lu,Bian Hu,Jiankui Zhou,Zhicong Zhao,Mingxuan Feng,Haiyan Zhang,Bin Shen,Xingxu Huang,Beicheng Sun,Mark J. Smyth,Chuan He,Qiang Xia

DOI: https://doi.org/10.1186/s12943-020-01257-8

IF: 37.3

2020-09-04

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Author Correction: Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression.

Xiang Hu,Chaofeng Han,Jing Jin,Kewei Qin,Hua Zhang,Tianliang Li,Nan Li,Xuetao Cao

DOI: https://doi.org/10.1038/s41598-020-76696-w

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Retraction: Corrigendum: Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fimmu.2021.716458

IF: 7.3

2021-06-14

Frontiers in Immunology

Abstract:[This retracts the article DOI: 10.3389/fimmu.2020.589346.].

immunology
RETRACTED: : Wogonin Reversed Resistant Human Myelogenous Leukemia Cells Via Inhibiting Nrf2 Signaling by Stat3/ NF-B Inactivation (vol 7, 39950, 2017) (retracted Article. See Vol. 12, 2022)

Xuefen Xu,Xiaobo Zhang,Yi Zhang,Lin Yang,Yicheng Liu,Shaoliang Huang,Lu,Lingyi Kong,Zhiyu Li,Qinglong Guo,Li Zhao

DOI: https://doi.org/10.1038/s41598-021-91964-z

IF: 4.6

2021-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
WITHDRAWN: the Role of TNFα in Promoting Hepatic MRP4 Expression Via the P38-Rb-e2f1 Pathway in Human Obstructive Cholestasis.

Wei Lian,Xiaocong Liu,Long Yang,Liangjun Zhang,Xinchan Feng,Wensheng Chen

DOI: https://doi.org/10.1016/j.bbrc.2016.01.061

IF: 3.1

2016-01-01

Biochemical and Biophysical Research Communications

Abstract:This article has been withdrawn at the request of the editor and the authors. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.

Ramesh Kudira,Zi F Yang,Immaculeta Osuji,Rebekah Karns,Priya Bariya,Liva Pfuhler,Mary Mullen,Amy Taylor,Hong Ji,Celine S Lages,Annika Yang vom Hofe,Tiffany Shi,Srikar Pasula,Joseph A Wayman,Anas Bernieh,Wujuan Zhang,Claire A Chougnet,David Hildeman,Gregory M Tiao,Stacey S Huppert,Sajay Subramanian,Nathan Salomonis,Emily Miraldi,Alexander Gerhard Miethke

DOI: https://doi.org/10.1101/2024.05.17.594680

2024-05-21

Abstract:Fibrosing cholangiopathies, including biliary atresia and primary sclerosing cholangitis, involve immune-mediated bile duct epithelial injury and hepatic bile acid (BA) retention (cholestasis). Regulatory T-cells (Tregs) can prevent auto-reactive lymphocyte activation, yet the effects of BA on this CD4 lymphocyte subset are unknown. Gene regulatory networks for hepatic CD4 lymphocytes in a murine cholestasis model revealed Tregs are polarized to Th17 during cholestasis. Following bile duct ligation, Stat3 deletion in CD4 lymphocytes preserved hepatic Treg responses. While pharmacological reduction of hepatic BA in MDR2-/- mice prompted Treg expansion and diminished liver injury, this improvement subsided with Treg depletion. A cluster of patients diagnosed with biliary atresia showed both increased hepatic Treg responses and improved 2-year native liver survival, supporting that Tregs might protect against neonatal bile duct obstruction. Together, these findings suggest liver BA determine Treg function and should be considered as a therapeutic target to restore protective hepatic immune responses.

Immunology
Publisher Correction: TGF-β Orchestrates Fibrogenic and Developmental EMTs Via the RAS Effector RREB1

Jie Su,Sophie M. Morgani,Charles J. David,Qiong Wang,Ekrem Emrah Er,Yun-Han Huang,Harihar Basnet,Yilong Zou,Weiping Shu,Rajesh K. Soni,Ronald C. Hendrickson,Anna-Katerina Hadjantonakis,Joan Massagué

DOI: https://doi.org/10.1038/s41586-019-1897-5

IF: 64.8

2020-01-01

Nature

Abstract:n Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Retraction Notice To: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 Mrna Translation in an M6a-Dependent Manner

Xiangxiang Liu,Jian Qin,Tianyi Gao,Chenmeng Li,Bangshun He,Bei Pan,Xueni Xu,Xiaoxiang Chen,Kaixuan Zeng,Mu Xu,Chengbin Zhu,Yuqin Pan,Huiling Sun,Li Sun,Tao Xu,Shukui Wang

DOI: https://doi.org/10.1016/j.omtn.2022.04.027

2022-01-01

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2020.09.036.].
Retraction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0313111

IF: 3.7

2024-11-06

PLoS ONE

Abstract:After publication of the Expression of Concern [3] on this article [1, 2], additional concerns were raised about results presented in Figs 1 and 11. Specifically:

multidisciplinary sciences

Retraction Note: Interactions Between Th1 Cells and Tregs Affect Regulation of Hepatic Fibrosis in Biliary Atresia Through the IFN-γ/STAT1 Pathway

RETRACTED ARTICLE:Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway

[Corrigendum] TLR4 mediates inflammation and hepatic fibrosis induced by chronic intermittent hypoxia in rats

Corrigendum to ‘therapeutic HNF4A Mrna Attenuates Liver Fibrosis in a Preclinical Model’ [J Hepatol (2021) 1420-1433]

Regulatory T Cells with a Defect in Inhibition on Co-Stimulation Deteriorated Primary Biliary Cholangitis

Regulatory T cells (Tregs) in liver fibrosis

Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice.

Publisher Correction: the Transcriptional Coactivator TAZ Regulates Reciprocal Differentiation of TH17 Cells and Treg Cells.

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum: TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure

Correction To: A Novel Role of Glutathione S-transferase A3 in Inhibiting Hepatic Stellate Cell Activation and Rat Hepatic Fibrosis.

Correction to: TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Author Correction: Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression.

Retraction: Corrigendum: Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis

RETRACTED: : Wogonin Reversed Resistant Human Myelogenous Leukemia Cells Via Inhibiting Nrf2 Signaling by Stat3/ NF-B Inactivation (vol 7, 39950, 2017) (retracted Article. See Vol. 12, 2022)

WITHDRAWN: the Role of TNFα in Promoting Hepatic MRP4 Expression Via the P38-Rb-e2f1 Pathway in Human Obstructive Cholestasis.

Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.

Publisher Correction: TGF-β Orchestrates Fibrogenic and Developmental EMTs Via the RAS Effector RREB1

Retraction Notice To: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 Mrna Translation in an M6a-Dependent Manner

Retraction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells